Class / Patent application number | Description | Number of patent applications / Date published |
514544000 | C(=O)O attached directly through the carbon to a benzene ring | 26 |
20080275115 | Insecticidal Compositions Suitable for Use in Preparation of Insecticidal Granular Fertilizer and Insecticidal Formulations - Insecticidal compositions suitable for use in preparation of insecticidal granular fertilizer and insecticidal formulations comprising a pyrethroid and a glycol present in a concentration of from 40.0% by weight to 99.0% by weight based upon the total weight of all components in the composition is disclosed. | 11-06-2008 |
20080275116 | Carboxilic acid derivatives - A compound represented by the following general formula (I) or a salt thereof, or a hydrate thereof or a solvate thereof having an inhibitory action against plasminogen activator inhibitor-1 (PAI-1): | 11-06-2008 |
20090143466 | Isolation of Atraric Acid, Synthesis of Atraric Acid Derivatives, and Use of Atraric Acid and the Derivatives Thereof for the Treatment of Benign Prostatic Hyperplasia, Prostate Carcinoma and Spinobulbar Muscular Atrophy - A method for isolating atraric acid from biological material, atraric acid derivatives, the chemical synthesis thereof, and the use of atraric acid and the derivatives thereof for treating or producing a medicament for treating benign prostate hyperplasia, prostate carcinoma or spinobulbar muscular atrophy is provided. In addition, a basic substance for the development of other agents used for treating benign prostate hyperplasia, prostate carcinoma, or spinobulbar muscular atrophy is provided. | 06-04-2009 |
20090253788 | Combinations of adapalene and benzoyl peroxide for treating acne lesions - Adapalene or a pharmaceutically acceptable salt thereof formulated into a pharmaceutical composition is useful for reducing the number of acne lesions, via daily topical application, in combination or in association with benzoyl peroxide (BPO); such treatment may be via administration of a pharmaceutical composition combining adapalene and BPO or by a concomitant application of two pharmaceutical compositions, one containing adapalene and the other containing BPO. | 10-08-2009 |
20090318551 | USES OF ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID - This invention relates to novel AKBA analogs of the formula I given below: | 12-24-2009 |
20100010086 | ANTIMICROBIAL THERAPY FOR INDWELLING CATHETERS AND FOR SANITIZING SURFACES - The invention relates to compositions that provide antimicrobial therapy for indwelling catheters and as topical disinfectants, and methods, devices and kits relating thereto. In one aspect, the invention relates to the infusion of a catheter lock solution into an indwelling catheter. Use of inventive compositions as catheter lock solutions advantageously aid in diminishing the effects of microbial infection in catheters and occlusion of the catheters. In other aspects, antimicrobial compositions are used to topically sanitize wounds, skin areas and/or other surfaces. An antimicrobial composition provided by the invention includes EDTA, a paraben, and optionally one or both of citrate and a photo-oxidant. | 01-14-2010 |
20100120910 | Cosmetic Compositions Comprising Esters Based on 2-Propylheptanol - The invention relates to the use of esters of 2-propylheptanol with benzoic acid and/or benzoic acid derivatives in cosmetic and/or pharmaceutical preparations. The compounds are distinguished by their particularly light sensory impression. | 05-13-2010 |
20100144873 | TREATMENT OF MYOCARDITIS USING FTS - Disclosed are methods of treating myocarditis by—administering to a human in need thereof effective amounts of FTS, or various analogs thereof, or a pharmaceutically acceptable salt thereof. | 06-10-2010 |
20100190856 | Novel Polyhydroxylated Compounds as Fatty Acid Synthase (FASN) Inhibitors - The present invention relates to new polyhydroxylated compounds and, in particular, to its activity as fatty acid synthase (FASN) inhibitors and to their use for the treatment of pathological states for which an inhibitor of this enzyme is indicated. The invention further relate to pharmaceutical compositions containing them and to a process for the preparation of such compounds. | 07-29-2010 |
20100240750 | CATHETER LOCK SOLUTION COMPRISING CITRATE AND A PARABEN - This invention relates to compositions, methods, devices and kits relating to the infusion of a catheter lock solution into an indwelling catheter. Inventive compositions, methods, devices and kits aid in diminishing the effects of microbial infection in catheters and occlusion of the catheters. A lock solution provided by the invention includes citrate and a paraben. The solution preferably has a density suitable for retention of the solution in a catheter during the lock period. Another lock solution provided by the invention includes citrate, a paraben and a photo-oxidant, such as, for example, methylene blue. | 09-23-2010 |
20110028545 | PROCESS FOR INCORPORATING ANTIMICROBIAL PRODUCTS INTO SOAP COMPOSITIONS - The present invention relates to a process for producing concentrates of antimicrobial active ingredients, the concentrates themselves and their use for producing solid, liquid or pasty body cleaning compositions, such as in particular soaps. | 02-03-2011 |
20110046220 | PARABEN COMPOUNDS - The invention relates to a | 02-24-2011 |
20110207817 | ANTI-INFLAMMATORY COMPOUNDS AND COMPOSITIONS THEREOF - This invention relates to alkyl parabens, their use as anti-inflammatory agents and compositions containing them. | 08-25-2011 |
20110301236 | HeLa-C3 Apoptosis Inducer from Garcinia paucinervis - A novel compound isolated from the plant | 12-08-2011 |
20120029075 | COMPOSITIONS CONTAINING C1 TO C7 ORGANIC ACID MONOGLYCERIDES AND GLYCEROL, THEIR PREPARATION AND USE AS ANTIBACTERIALS AND ANTI-MOULD AGENTS - Described are antibacterial and anti-mould compositions containing high amounts of C | 02-02-2012 |
20120095094 | PROCESS FOR COSMETIC TREATMENT USING FERUTININE FROM FERULA GENUS PLANTS - The invention relates to a process for cosmetic treatment, including the reduction of superficial and deep wrinkles, using ferutinine from | 04-19-2012 |
20120220654 | THERAPEUTIC SOLUTION CONCENTRATE - A concentrated poly(ethylene glycol) solution that has good stability for extended storage is provided for use as a laxative. The concentrated solution comprises water, sodium benzoate, poly(ethylene glycol), and enough acid to yield a solution having a pH at 25° C. in the range 3.0-5.0. It is prepared and packaged to minimize the accumulation of degradation products. | 08-30-2012 |
20120238624 | FORMULATIONS FOR THE TREATMENT OF PAIN - Formulations and methods are provided for the treatment of pain, and neuropathic pain in particular. The formulations are eutectic mixtures of a capsaicinoid and a local anesthetic agent and/or an anti-pruritic agent. | 09-20-2012 |
20120277312 | Ethylgallate and Related Compounds as a Treatment for Sepsis and Septic Shock - The use of ethyl gallate methyl gallate or 3,4-dihydroxybenzoate for treatment of septic shock Said compounds may also prophylactically treat septic shock via administration to a subject before the development of a fall in blood pressure. | 11-01-2012 |
20120277313 | COSMETIC COMPOSITION STABILIZED HIGHER OILY PART - The present invention relates to a cosmetic composition having a high content of a stable oil phase, and more particularly to a cosmetic composition, which combines advantages of spreadability and softness of an oil-in-water type with emollient effect and water resistance of a water-in-oil type as a resulting of stabilizing, based on the total weight of the composition, 30-56 wt % of an oily component by multiple emulsification of W/O/W, and which provides skin moisturizing and softening ef-fects by a large amount of oil components, and also which allows irritations caused by active ingredients to be relieved by a high content of the oily component. | 11-01-2012 |
20120277314 | CATHETER LOCK SOLUTION COMPRISING CITRATE AND A PARABEN - This invention relates to compositions, methods, devices and kits relating to the infusion of a catheter lock solution into an indwelling catheter. Inventive compositions, methods, devices and kits aid in diminishing the effects of microbial infection in catheters and occlusion of the catheters. A lock solution provided by the invention includes citrate and a paraben. The solution preferably has a density suitable for retention of the solution in a catheter during the lock period. Another lock solution provided by the invention includes citrate, a paraben and a photo-oxidant, such as, for example, methylene blue. | 11-01-2012 |
20130143964 | SYMPATHETIC INHIBITOR, AND COSMETIC COMPOSITION, FOOD, AND SUNDRY ARTICLE CONTAINING THE SAME - Disclosed are a sympathetic inhibitor allowing more effective inhibition of activity of a sympathetic nerve, as well as a cosmetic composition, a food, and a sundry article containing the same. Ethyl 4-methoxybenzoate is efficacious for quieting down the activity of the sympathetic nerve. The sympathetic inhibitor, the cosmetic composition, the food and the sundry article containing the same enable more effective inhibition of the activity of the sympathetic nerve. | 06-06-2013 |
20130178526 | CATHETER LOCK SOLUTION COMPRISING CITRATE AND A PARABEN - This invention relates to compositions, methods, devices and kits relating to the infusion of a catheter lock solution into an indwelling catheter. Inventive compositions, methods, devices and kits aid in diminishing the effects of microbial infection in catheters and occlusion of the catheters. A lock solution provided by the invention includes citrate and a paraben. The solution preferably has a density suitable for retention of the solution in a catheter during the lock period. Another lock solution provided by the invention includes citrate, a paraben and a photo-oxidant, such as, for example, methylene blue. | 07-11-2013 |
20130178527 | METHOD FOR PREVENTION OR TREATMENT OF DEGENERATIVE NEUROLOGIAL BRAIN DISORDERS - The present invention relates to a method for the prevention or treatment of degenerative neurological brain disorders and, more specifically, relates to a method for the prevention or treatment of degenerative neurological brain disorders, such as Parkinson's disease, Alzheimer's dementia (senile dementia), stroke, Lou Gehrig's disease, Pick's disease, Creutzfeldt-Jakob disease, Huntington's disease, progressive supranuclear palsy, spinocerebellar degeneration, cerebellar atrophy, multiple sclerosis, post-traumatic stress disorder, and amnesia. The method includes administering to a subject in need thereof a therapeutically effective amount of a composition, wherein the composition contains a paraben compound as an active ingredient having effects that are useful in combating oxidation to remove active oxygen, suppressing cell-death, improving impaired movement, and enhancing declining memory. | 07-11-2013 |
20140088193 | VIRAL INHIBITOR COMPOSITION FOR IN VIVO THERAPEUTIC USE - The present invention concerns a pharmaceutical composition comprising a compound of formula A being (2,3(dihydroxy), 5[3(1,2)butadiene], 1(3hydroxy,3methyl,4pentene)benzene) and/or a compound of formula B being (2,3(dihydroxy), 5[3(1,2)butadiene], 2[2methylbutane]benzenal) and/or a compound of formula C being (2,3(dihydroxy), 5[3(1,2)butadiene], 2hydroxy,3butene benzoate) or a combination thereof for use as a medicament or for in vivo use in treatment and prevention of diseases caused by DNA enveloped viruses, DNA non-enveloped viruses, RNA enveloped viruses and RNA non-enveloped viruses. | 03-27-2014 |
20150336874 | MIXTURES OF CANNABINOID COMPOUNDS, AND PRODUCTION AND USE THEREOF - Specific compositions comprising one or multiple (cannabinoid) compound(s) of formula (A) and/or one or multiple salt(s) thereof are described as well as methods for their manufacture. | 11-26-2015 |